Redshiftbio

News & Press

May 13, 2024

RedShiftBio Launches Aurora TX: Revolutionizing RNA and Protein Analysis with Ultra-Sensitive Microfluidic Modulation Spectroscopy and Thermal Ramping Capability

News & Press

April 1, 2024

RedShiftBio Welcomes Sebastian Arevalo as New Sales Leader

News & Press

March 7, 2024

Tom O’Lenic joins RedShiftBio as Chief Executive Officer

News & Press

August 30, 2023

RedShift BioAnalytics’ HaLCon Analyzer Awarded Best of Show at the 15th Annual Bioprocessing Summit

News & Press

August 24, 2023

RedShift BioAnalytics Announces Distribution Agreement with Flownamics for The Director™ Liquid Handler.

News & Press

July 13, 2023

RedShift BioAnalytics Announces Launch of Aurora Second-Generation MMS Platform , for Ultra-Sensitive Biophysical Characterization of Biomolecules

News & Press

June 7, 2023

RedShift BioAnalytics Launches HaLCon™ Analyzer, ProvidingSimple and Accurate On-Demand Protein Titer Measurements for Bioprocess Development and Manufacturing

News & Press

May 17, 2023

RedShift BioAnalytics Announces Acquisition of Novel Liquid Chromatography Protein Analyzer Technology

News & Press

May 2, 2022

RedShift BioAnalytics Announces Launch of Next Generation Apollo for Ultra-Sensitive Biophysical Characterization of Biomolecules

News & Press

March 30, 2022

RedShift BioAnalytics announces partnership with DKSH, expanding the MMS market in Asia Pacific

News & Press

November 16, 2021

Strategic relationship between SCIEX and RedShiftBio® expands the reach of disruptive technology to address challenges with rapid secondary structure assessment of biotherapeutics

News & Press

October 18, 2021

RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures

News & Press

October 6, 2021

RedShift BioAnalytics Celebrates Opening of StructIR Scientific Services Lab with the Launch of the StructIR Lab Grant Program

News & Press

September 7, 2021

RedShift BioAnalytics Appoints Amol Chaubal, CFO of Waters Corporation, to Board of Directors

News & Press

February 18, 2021

RedShift BioAnalytics Announces 500% Sales Growth in 2020 and Closing of Additional Financing

News & Press

October 15, 2020

RedShiftBio Expands Team to Support Demand for AQS³pro

News & Press

October 5, 2020

Peer-reviewed study demonstrates higher sensitivity, repeatability, and utility relative to conventional FTIR

News & Press

September 9, 2020

RedShiftBio’s AQS³pro Goes Global With Appointment of Spinco Biotech as Exclusive Indian Distributor

News & Press

June 16, 2020

RedShiftBio Appoints Primetech as Exclusive Distributor in Japan

News & Press

May 7, 2020

RedShiftBio Appoints Topbiox as Exclusive Distributor in China

News & Press

April 16, 2020

Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics

News & Press

January 29, 2020

RedShiftBio Appoints Julien Bradley as CEO and Closes $18M Series D Round Funding

News & Press

December 2, 2019

The AQS³pro - A Hit For The Second Year Running at PEGS Europe

News & Press

November 21, 2019

Accelerating Novel And Complex Modules Towards CMC Success

News & Press

November 20, 2019

MIBio 2019: A Huge Success for RedShiftBio

News & Press

October 21, 2019

Monitoring protein aggregation in biotherapeutics - a hot topic at the 9th annual American Drug Delivery & Formulation Summit

News & Press

August 23, 2019

Protein Aggregation Monitoring: Bioprocessing Summit 2019

News & Press

August 20, 2019

Researchers From Numerous Disciplines Gather At The Colorado Protein Stability Conference

News & Press

May 7, 2019

RedShiftBio’s AQS³pro Changes the Game in the Detection and Treatment of Alzheimer’s Disease

News & Press

April 23, 2019

Inspiring innovative biotherapeutic protein drug development at PEGS 2019

News & Press

April 23, 2019

Scientists See Change in Higher Order Structure with MMS at HOS 2019

News & Press

April 3, 2019

RedShiftBio Shipping AQS³pro as Industry Endorsements Expand

News & Press

March 13, 2019

Higher Order Structure: The Hot Topic of Biotherapeutics Analytical Summit

News & Press

February 15, 2019

AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019

News & Press

February 15, 2019

RedShiftBio Shines at PepTalk 2019

News & Press

February 15, 2019

RedShiftBio Joined Thought Leaders at Biotherapeutics and Vaccines Development (Gordon Research Conference)

News & Press

January 31, 2019

RedShiftBio’s AQS³pro: Finalist in The Prism Awards 2019

News & Press

January 28, 2019

Photonics Media publishes article on Technological Synergies Move Spectroscopy Out of the Lab

News & Press

December 14, 2018

RedShiftBio’s AQS³pro Wins a ‘The Analytical Scientist Innovation Award’ (TASIA) 2018

News & Press

October 31, 2018

American Pharmaceutical Review publishes article on MMS by Karan K. Shah Principal Development Associate Analytical and Pharmaceutical Sciences ImmunoGen, Inc.

News & Press

October 5, 2018

Complex Protein Studies Demand Dynamic Techniques: Article in Biopharma International

News & Press

August 26, 2018

Immunogen Presents MMS Data in Talk at Bioprocessing Summit 2018

News & Press

August 17, 2018

Workshop on Protein Aggregation and Immunogenicity 2018

News & Press

August 17, 2018

RedShiftBio Strengthens Focus on Applications with New Hire

News & Press

July 2, 2018

Spectroscopy North America publishes peer-reviewed paper on MMS from Brent Kendrick of Elion Labs, Eugene Ma and Libo Wang of RedShiftBio

News & Press

May 15, 2018

RedShiftBio Expands Team to Support Launch of FlagShip AQS³®pro System for Protein Characterization

News & Press

May 11, 2018

RedShiftBio Stole the Show at PEGS with the Launch of AQS³pro

News & Press

May 10, 2018

Instrument Business Outlook interviews RedShiftBio CCO Jeff Zonderman on the launch of the AQS³pro

News & Press

May 1, 2018

RedShiftBio Launches New Protein Characterization Instrument System - AQS³pro See Change™ with the new AQS³pro System for protein characterization from RedShiftBio.

News & Press

May 1, 2018

Spectroscopy Europe highlights the launch of the AQS³pro

News & Press

April 23, 2018

RedShiftBio presents MMS data at HOS 2018

News & Press

April 3, 2018

RedShiftBio at Biotherapeutics Analytical Summit 2018

News & Press

March 15, 2018

RedShiftBio Announces Collaboration Trial Completion ,Academic and Industrial Collaborators Validate New Bioanalytical Platform

News & Press

March 12, 2018

Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization

News & Press

February 28, 2018

Celebrating new analytical techniques to accelerate the development of life saving biotherapeutics at PepTalk

News & Press

June 2, 2017

Jeffrey Zonderman Joins RedShiftBio as its Chief Commercial Officer

News & Press

March 15, 2017

RedShiftBio Inc. Completes $11.0 million Series C Financing

Unfortunately, we couldn't find any News Articles matching your criteria.

Request a Demo Today!